Boston Scientific to acquire NxThera for up to $406M

Boston Scientific has entered a definitive agreement to acquire NxThera, a privately-held company that developed the Rezūm system for treating benign prostatic hyperplasia. The deal includes an upfront cash payment of $306 million and up to $100 million in milestone payments.

“Boston Scientific today announced that it has entered into a definitive agreement to acquire NxThera, a privately-held company based in Maple Grove, Minnesota.”prnewswire.com

• 3 sources
• prnewswire.comBoston Scientific Announces Agreement To Acquire NxTheraBoston ScientificMar 21, 2018
• news.bostonscientific.comBoston Scientific Announces Acquisition of nVision Medical CorporationApr 16, 2018
• medicaldevice-network.comM&As this week: Air Liquide, Flexan, Boston Scientific - Medical Device NetworkApr 19, 2018

Summarized from public sources; check the original articles before acting on it.